Lead optimization of rivastigmine-like hybrids: Impact of nitro group and halogen substitution on multi-target anti-Alzheimer's activity.

Leuci R, Paparella M, Cerini M, Simic S, Chaves S, Carrieri A, Tortorella P, Loiodice F, Laghezza A, Santos MA, Wackerlig-Damle J, Piemontese L

Open source

DOI
10.1016/j.bmc.2026.118760
Published
2026 Oct
Container
Bioorganic & medicinal chemistry
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.bmc.2026.118760,
  title = {Lead optimization of rivastigmine-like hybrids: Impact of nitro group and halogen substitution on multi-target anti-Alzheimer's activity.},
  author = {Leuci R and Paparella M and Cerini M and Simic S and Chaves S and Carrieri A and Tortorella P and Loiodice F and Laghezza A and Santos MA and Wackerlig-Damle J and Piemontese L},
  year = {2026},
  journal = {Bioorganic \& medicinal chemistry},
  doi = {10.1016/j.bmc.2026.118760},
  url = {https://doi.org/10.1016/j.bmc.2026.118760}
}

RIS

TY  - JOUR
TI  - Lead optimization of rivastigmine-like hybrids: Impact of nitro group and halogen substitution on multi-target anti-Alzheimer's activity.
AU  - Leuci R
AU  - Paparella M
AU  - Cerini M
AU  - Simic S
AU  - Chaves S
AU  - Carrieri A
AU  - Tortorella P
AU  - Loiodice F
AU  - Laghezza A
AU  - Santos MA
AU  - Wackerlig-Damle J
AU  - Piemontese L
PY  - 2026
JO  - Bioorganic & medicinal chemistry
DO  - 10.1016/j.bmc.2026.118760
UR  - https://doi.org/10.1016/j.bmc.2026.118760
ER  - 

APA

R, L., M, P., M, C., S, S., S, C., A, C., P, T., F, L., A, L., MA, S., J, W., & L, P. (2026). Lead optimization of rivastigmine-like hybrids: Impact of nitro group and halogen substitution on multi-target anti-Alzheimer's activity.. Bioorganic & medicinal chemistry. https://doi.org/10.1016/j.bmc.2026.118760

Source records